The success of GLP-1 receptor agonists/analogues has transformed metabolic disease treatment while demonstrating the potential of engineered peptides to deliver long-acting, highly targeted therapies.

Reach customers where they live, work, and scroll. With 665,386 unique visits in the past 28 days alone, timesleader.com stands as one of the most highly trafficked websites in Northeastern ...

Rep. David Rowe, Chairman of the Pennsylvania House Republican Policy Committee, far right, conducted a hearing on Tuesday at the Friedman JCC in Kingston titled ‘Small Communities, Big Costs: ...

Becker, a multi-practice commercial law firm with attorneys, lobbyists, and other professionals, is pleased… OneDigital and Kistler Tiffany Benefits is proud to announce that it has been awarded the… ...